3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Carboplatin
29
pembrolizumab
25
Pemetrexed
25
Specimen Handling
22
Cisplatin
20
Magnetic Resonance Spectroscopy
18
Paclitaxel
15
Gemcitabine
13
Docetaxel
12
durvalumab
9
Nivolumab
8
osimertinib
7
Taxes
7
Immunoglobulin G
7
Disulfides
7
130-nm albumin-bound paclitaxel
7
atezolizumab
6
Etoposide
6
Platinum
5
Cetuximab
5
1,2-diaminocyclohexaneplatinum II citrate
5
X-Rays
4
Ramucirumab
4
Radiotherapy
4
Radiation
4
Observation
4
Interviews as Topic
4
Biopsy
4
Albumin-Bound Paclitaxel
4
patritumab deruxtecan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Radionuclide Imaging
×
30 days
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled